UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026464
Receipt number R000030399
Scientific Title Clinical utility of rapid diagnositc test in the patients with respiratory tract infection
Date of disclosure of the study information 2017/03/08
Last modified on 2021/02/15 11:21:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical utility of rapid diagnositc test in the patients with respiratory tract infection

Acronym

Clinical utility of rapid diagnositc test in the patients with respiratory tract infection

Scientific Title

Clinical utility of rapid diagnositc test in the patients with respiratory tract infection

Scientific Title:Acronym

Clinical utility of rapid diagnositc test in the patients with respiratory tract infection

Region

Japan


Condition

Condition

Respiratory tract infection

Classification by specialty

Pneumology Laboratory medicine Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Verification of utility of rapid diagnostic test

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Concrdance rate of rapid diagnostic test with clinical diagnosis

Key secondary outcomes

Comparison of sensitivity and specificity between rapid diagnostic test with antigen test


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with respiratory symptom

Key exclusion criteria

The patients wit bleeding tendency

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Katsunori
Middle name
Last name Yanagihara

Organization

Nagasaki University Graduate School of Biomedical Sciences

Division name

Department of Laboratry Medicine

Zip code

852-8501

Address

1-7-1 Sakamoto, Nagasaki city, Nagasaki, Japan

TEL

095-819-7574

Email

k-yanagi@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Norihito
Middle name
Last name Kaku

Organization

Nagasaki University Graduate School of Biomedical Sciences

Division name

Department of Laboratry Medicine

Zip code

852-8501

Address

1-7-1 Sakamoto, Nagasaki city, Nagasaki, Japan

TEL

095-819-7574

Homepage URL


Email

kaku-ngs@umin.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

SYSMEX bioMerieux Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Japanese Red Cross Nagasaki Genbaku Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Hospital

Address

1-7-1, Sakamoto, Nagasaki city

Tel

095-819-7905

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 08 Day


Related information

URL releasing protocol

UMIN000026464

Publication of results

Published


Result

URL related to results and publications

https://www.sciencedirect.com/science/article/pii/S1341321X1830151X?via%3Dihub

Number of participants that the trial has enrolled

50

Results

Fifty patients were enrolled. FilmArray RP detected the pathogens in 28 patients. The common pathogens were influenza virus (n = 14), respiratory syncytial virus (n = 6), and human rhinovirus (n = 6). Of the 14 patients with influenza virus, 6 were negative for the antigen test. The physicians diagnosed and treated the patients without the result of FilmArray in this study. Of the patients with positive FilmArray RP, 9 were treated with antibiotics; however, bacteria were detected in only 3 patients.

Results date posted

2019 Year 03 Month 20 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

This was a prospective observational study in influenza epidemics that enrolled adult outpatients who visited a hospital with respiratory tract infection symptoms.

Participant flow

We enrolled adult outpatients who visited the Department of Respiratory Medicine and the Japanese Red Cross Nagasaki Genbaku Hospital with respiratory tract infection symptoms such as cough, sputum, sore throat, nasal mucus, headache, dyspnea, or hypoxemia. Based on the physician's discretion, chest X-ray and microorganism tests, such as gram stain, culture, and influenza antigen test, were performed at the Japanese Red Cross Nagasaki Genbaku Hospital. Informed consent and nasopharyngeal swabs for FilmArray RP were obtained from all patients. The FilmArray RP analysis was performed at Nagasaki University Hospital; however, the results were not reported to the physicians.

Adverse events

No adverse events

Outcome measures

Detection of Viruses

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 11 Month 10 Day

Date of IRB

2015 Year 12 Month 19 Day

Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date

2016 Year 04 Month 30 Day

Date of closure to data entry

2016 Year 04 Month 30 Day

Date trial data considered complete

2017 Year 03 Month 31 Day

Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information

The results of rapid diagnostic test do not report to the physicians.
We compare the result of rapid diagnostic test with clinical diagnosis by the physicians.


Management information

Registered date

2017 Year 03 Month 08 Day

Last modified on

2021 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030399


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name